ES520059A0 - Un procedimiento para la preparacion de pirimidin-2-onas sustituidas. - Google Patents

Un procedimiento para la preparacion de pirimidin-2-onas sustituidas.

Info

Publication number
ES520059A0
ES520059A0 ES520059A ES520059A ES520059A0 ES 520059 A0 ES520059 A0 ES 520059A0 ES 520059 A ES520059 A ES 520059A ES 520059 A ES520059 A ES 520059A ES 520059 A0 ES520059 A0 ES 520059A0
Authority
ES
Spain
Prior art keywords
group
ring
groups
heterocyclic
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES520059A
Other languages
English (en)
Other versions
ES8403879A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nyegaard and Co AS
Original Assignee
Nyegaard and Co AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard and Co AS filed Critical Nyegaard and Co AS
Publication of ES8403879A1 publication Critical patent/ES8403879A1/es
Publication of ES520059A0 publication Critical patent/ES520059A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1742—Unsaturated ethers containing halogen containing six-membered aromatic rings with halogen atoms bound to the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrane Compounds (AREA)
ES520059A 1982-02-24 1983-02-24 Un procedimiento para la preparacion de pirimidin-2-onas sustituidas. Granted ES520059A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8205483 1982-02-24

Publications (2)

Publication Number Publication Date
ES8403879A1 ES8403879A1 (es) 1984-04-01
ES520059A0 true ES520059A0 (es) 1984-04-01

Family

ID=10528583

Family Applications (1)

Application Number Title Priority Date Filing Date
ES520059A Granted ES520059A0 (es) 1982-02-24 1983-02-24 Un procedimiento para la preparacion de pirimidin-2-onas sustituidas.

Country Status (10)

Country Link
US (1) US4539324A (es)
EP (1) EP0087326B1 (es)
JP (1) JPS58159479A (es)
AT (1) ATE27153T1 (es)
AU (1) AU1179883A (es)
DE (1) DE3371512D1 (es)
DK (1) DK83783A (es)
ES (1) ES520059A0 (es)
NO (1) NO161440C (es)
ZA (1) ZA831247B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596870A (en) * 1981-01-09 1986-06-24 Nyegaard & Co. A.S. Substituted pyrimidin-2-ones and the salts thereof
GB2135992B (en) * 1983-01-11 1986-09-24 Nyegaard & Co As Substituted pyrimidines and processes for their preparation
GB8411291D0 (en) * 1984-05-02 1984-06-06 Nyegaard & Co As Chemical compounds
CA2757188A1 (en) * 2009-03-30 2010-10-07 Astellas Pharma Inc. Pyrimidine compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911391A (es) * 1972-05-31 1974-01-31
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
US4044008A (en) * 1976-10-06 1977-08-23 Morton-Norwich Products, Inc. 1-[2-Hydroxy-3-(2-naphthoxy)propyl]-2(1H)pyrimidone hydrochloride
ES498337A0 (es) * 1980-01-07 1982-06-01 Nyegaard & Co As Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas
AU549117B2 (en) * 1980-01-10 1986-01-16 Nyegaard & Co. A/S Pyrimidine-2-sulphides and their 5-oxides
CA1160226A (en) * 1980-07-15 1984-01-10 Gordon H. Phillipps Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
US4596870A (en) * 1981-01-09 1986-06-24 Nyegaard & Co. A.S. Substituted pyrimidin-2-ones and the salts thereof
ZA826660B (en) * 1981-09-11 1983-08-31 Nyegaard & Co As Substituted pyrimid-2-ones,the salts thereof,processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK83783A (da) 1983-08-25
US4539324A (en) 1985-09-03
DE3371512D1 (en) 1987-06-19
EP0087326A1 (en) 1983-08-31
NO161440B (no) 1989-05-08
ES8403879A1 (es) 1984-04-01
NO830644L (no) 1983-08-25
ZA831247B (en) 1984-04-25
EP0087326B1 (en) 1987-05-13
NO161440C (no) 1989-08-16
ATE27153T1 (de) 1987-05-15
AU1179883A (en) 1983-09-01
DK83783D0 (da) 1983-02-24
JPS58159479A (ja) 1983-09-21

Similar Documents

Publication Publication Date Title
ES539614A0 (es) Procedimiento para preparar acilanilidas.
SE7907121L (sv) Ftalimidinderivat
DK159148C (da) Analogifremgangsmaade til fremstilling af tranexamsyrederivater
ES526765A0 (es) Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina
MY141579A (en) Pyrrolidine-2-one derivatives, processes for their preparation, composition containing them and their use as factor xa inhibitors
ES8304945A1 (es) "un procedimiento para la preparacion de pirimidin-2-onas sustituidas".
SE8107387L (sv) Nya fenylalkylaminer, framstellning derav och anvendning som lekemedel
NO161678C (no) Analogifremgangsm te for fremstilling av metylendifosfonsyrederivater med antireumatiske egenskaper.
DE3371512D1 (en) Substituted pyrimidin-2-ones and the salts thereof
ES496388A0 (es) Procedimiento para la obtencion de un 1,1-dioxido de 6h-1,2,4,6-tiatriazina
FI864018A0 (fi) Tetrahydro- -karboliner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ES8201979A1 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
RO77564A (ro) Procedeu pentru prepararea unor n-pirazelilmetil-halogenacetanilide substituite
ES8800663A1 (es) Procedimiento para preparar compuestos arilsulfonicos.
DK167580A (da) Fremgangsmaade til fremstilling af oxazolin- og thiazolinderivater
ES464480A1 (es) Procedimiento para preparar esteres de acidos bencenosulfonicos sustituidos.
ES543801A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo aminopropanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias
CH653840GA3 (en) Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds
SE7707445L (sv) Organiska foreningar, deras framstellning och anvendning
EP0160573A3 (en) Pyrimidinone derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201